Settlement on Zyprexa Hurts Results at Eli Lilly
123182
Eli Lilly & Company also forecast 2007 earnings at the low end of Wall Street estimates.
515541
INDIANAPOLIS, July 24  â Eli Lilly, with help from its core medicines Zyprexa and Cymbalta, beat Wall Streetâs second-quarter expectations Tuesday, although profits fell 19 percent at the pharmaceutical company because of acquisition costs.
669191
Eli Lilly and Co. has downplayed for about 10 years the risks associated with Zyprexa, which treats schizophrenia, The New York Times said on its Web site Sunday, citing internal documents from the drug maker and e-mail messages of its managers.
110931
na settlement that the New York State attorney general said would transform the drug industry, GlaxoSmithKline agreed today to post on its Web site the results of all clinical trials involving its drugs.
112414
Internal documents show that the company knew of serious side effects of Zyprexa, its best-selling medication for schizophrenia.
2756
NEW YORK - The pharmaceutical industry has endured a disastrous 2004, and the aftermath will linger into the new year. Regulators at the Food and Drug Administration were expected to take a more cautious approach
653551
Pfizer Inc., the world&#39;s largest drugmaker, agreed to pay $430 million to resolve personal-injury claims against a subsidiary that sold products containing asbestos in the 1970s.
243267
Confidential marketing documents about Eli Lilly's best-selling schizophrenia drug, Zyprexa, must be returned to the company by a doctor and a lawyer who conspired to leak them to the press, a federal judge ruled yesterday.
333819
Company says FDA has approved Cymbalta, OK&#39;d last month as antidepression, to treat diabetic pain. NEW YORK  - Eli Lilly and Co.
262411
The label on the schizophrenia drug Zyprexa now acknowledges its tendency to cause weight gain, high blood sugar, high cholesterol and other metabolic problems.
162917
Confidential company documents obtained by a leading medical journal suggest that drug giant Eli Lilly &amp; Co. was aware that its antidepressant Prozac was linked to troubling
443779
Investors in pharmaceuticals were dealt a triple whammy on Friday as Pfizer Inc, AstraZeneca Plc and Eli Lilly and Co all shocked the market with bad news about key products.
475153
Eli Lilly (LLY:NYSE - news - research) Thursday confirmed earnings guidance and updated its drug pipeline efforts. The Indianapolis-based company still expects EPS of 73 cents to 75 cents and $2.80 to $2.82
64070
The drug maker said its fourth-quarter profit fell 70 percent from a year-ago period that included the sale of its consumer health business, but adjusted profit topped Wall Street expectations.
353925
Eli Lilly and Co. LLY.N on Wednesday  reported a fourth-quarter net loss on charges for restructuring  and taxes related to the return of overseas profits as sales of  prescription drugs rose only slightly.
402815
NEW YORK -- Pharmaceutical company Eli Lilly and Co. on Thursday issued 2007 earnings estimates that are below Wall Street's current expectations.
763548
Shares in Repligen Corp. fell nearly 18 percent yesterday after the Waltham biotech company settled a patent suit with ImClone Systems Inc. for less than some investors expected. Under terms of the deal, ImClone agreed to pay $65 million to end the case.